{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T02:42:41Z","timestamp":1789094561621,"version":"build-2803163510"},"reference-count":110,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008897","name":"Janssen Pharmaceutica","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017540","name":"National Heart Lung and Blood Institute Division of Intramural Research","doi-asserted-by":"publisher","award":["1R13HL172559-01"],"award-info":[{"award-number":["1R13HL172559-01"]}],"id":[{"id":"10.13039\/100017540","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011096","name":"Jazz Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011096","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.jtct.2025.01.885","type":"journal-article","created":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T20:10:46Z","timestamp":1737576646000},"page":"347.e1-347.e17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Pediatric Transplant and Cellular Therapy Consortium RESILIENT Conference on Pediatric Chronic Graft-versus-Host Disease Survivorship after Hematopoietic Cell Transplantation: Part II. Organ Dysfunction and Immune Reconstitution Considerations for Children with Chronic Graft-versus-Host Disease after Hematopoietic Cell Transplantation"],"prefix":"10.1016","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8281-3627","authenticated-orcid":false,"given":"Blachy J","family":"D\u00e1vila Salda\u00f1a","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirk R","family":"Schultz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5172-723X","authenticated-orcid":false,"given":"Archana","family":"Ramgopal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie R.","family":"Boiko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1839-4397","authenticated-orcid":false,"given":"Kristen","family":"Beebe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5021-0714","authenticated-orcid":false,"given":"Paul A.","family":"Carpenter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherwin S","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5571-2775","authenticated-orcid":false,"given":"Sophie","family":"Paczesny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paibel","family":"Aguayo-Hiraldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4493-8757","authenticated-orcid":false,"given":"Geoffrey D.E.","family":"Cuvelier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2896-1113","authenticated-orcid":false,"given":"Seth J.","family":"Rotz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine N.","family":"Duncan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten M","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.jtct.2025.01.885_bib0001","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.jtct.2022.05.038","article-title":"Toward a better understanding of the atypical features of chronic graft-versus-host disease: a report from the 2020 National Institutes of Health Consensus Project Task Force","volume":"28","author":"Cuvelier","year":"2022","journal-title":"Transplant Cell Ther"},{"issue":"7","key":"10.1016\/j.jtct.2025.01.885_bib0002","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.jtct.2021.03.033","article-title":"National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IIa. The 2020 Clinical Implementation and Early Diagnosis Working Group report","volume":"27","author":"Kitko","year":"2021","journal-title":"Transplant Cell Ther"},{"issue":"6","key":"10.1016\/j.jtct.2025.01.885_bib0003","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.jtct.2021.02.035","article-title":"National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2020 Etiology and Prevention Working Group report","volume":"27","author":"Williams","year":"2021","journal-title":"Transplant Cell Ther"},{"issue":"3","key":"10.1016\/j.jtct.2025.01.885_bib0004","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.beha.2008.06.003","article-title":"Immune reconstitution and implications for immunotherapy following haematopoietic stem cell transplantation","volume":"21","author":"Williams","year":"2008","journal-title":"Best Pract Res Clin Haematol"},{"issue":"4","key":"10.1016\/j.jtct.2025.01.885_bib0005","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.jtct.2023.12.001","article-title":"International recommendations for screening and preventative practices for long-term survivors of transplantation and cellular therapy: a 2023 update","volume":"30","author":"Rotz","year":"2024","journal-title":"Transplant Cell Ther"},{"issue":"10","key":"10.1016\/j.jtct.2025.01.885_bib0006","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.jtct.2021.06.001","article-title":"National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2020 Highly Morbid Forms report","volume":"27","author":"Wolff","year":"2021","journal-title":"Transplant Cell Ther"},{"issue":"8","key":"10.1016\/j.jtct.2025.01.885_bib0007","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.bbmt.2013.05.021","article-title":"Outcomes of allogeneic hematopoietic cell transplantation in patients with dyskeratosis congenita","volume":"19","author":"Gadalla","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"10.1016\/j.jtct.2025.01.885_bib0008","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1053\/j.ackd.2021.11.003","article-title":"Kidney disease following hematopoietic stem cell transplantation","volume":"29","author":"Abudayyeh","year":"2022","journal-title":"Adv Chronic Kidney Dis"},{"issue":"5","key":"10.1016\/j.jtct.2025.01.885_bib0009","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1097\/01.tp.0000230373.82376.46","article-title":"Risk factors and severe outcome in thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation","volume":"82","author":"Uderzo","year":"2006","journal-title":"Transplantation"},{"issue":"3","key":"10.1016\/j.jtct.2025.01.885_bib0010","doi-asserted-by":"crossref","first-page":"364","DOI":"10.3324\/haematol.2009.017244","article-title":"Iron overload in hematologic malignancies and outcome of allogeneic hematopoietic stem cell transplantation","volume":"95","author":"Koreth","year":"2010","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.jtct.2025.01.885_bib0011","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1182\/blood.2019000216","article-title":"Benefits and challenges with diagnosing chronic and late acute GVHD in children using the NIH consensus criteria","volume":"134","author":"Cuvelier","year":"2019","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.jtct.2025.01.885_bib0012","doi-asserted-by":"crossref","first-page":"712.e1","DOI":"10.1016\/j.jtct.2022.07.014","article-title":"Association of chronic graft-versus-host disease with late effects following allogeneic hematopoietic cell transplantation for children with hematologic malignancy","volume":"28","author":"Lee","year":"2022","journal-title":"Transplant Cell Ther"},{"issue":"11","key":"10.1016\/j.jtct.2025.01.885_bib0013","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1016\/j.bbmt.2015.07.025","article-title":"Long-term morbidity and mortality in children with chronic graft-versus-host disease classified by National Institutes of Health Consensus Criteria after allogeneic hematopoietic stem cell transplantation","volume":"21","author":"Inagaki","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"10.1016\/j.jtct.2025.01.885_bib0014","doi-asserted-by":"crossref","first-page":"36","DOI":"10.2991\/chi.d.190314.001","article-title":"Challenges in conducting studies in chronic graft-versus-host disease","volume":"1","author":"Pusic","year":"2019","journal-title":"Clin Hematol Int"},{"issue":"12","key":"10.1016\/j.jtct.2025.01.885_bib0015","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1007\/s00431-019-03447-z","article-title":"Lung evaluation in 10-year survivors of pediatric allogeneic hematopoietic stem cell transplantation","volume":"178","author":"L'Excellent","year":"2019","journal-title":"Eur J Pediatr"},{"issue":"4","key":"10.1016\/j.jtct.2025.01.885_bib0016","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1182\/blood-2016-08-693507","article-title":"How I treat bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation","volume":"129","author":"Williams","year":"2017","journal-title":"Blood"},{"issue":"23","key":"10.1016\/j.jtct.2025.01.885_bib0017","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1182\/blood.2021011497","article-title":"Checkpoint-blocked T cells checkmate AML","volume":"137","author":"Williams","year":"2021","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.jtct.2025.01.885_bib0018","doi-asserted-by":"crossref","first-page":"328.e1","DOI":"10.1016\/j.jtct.2022.02.002","article-title":"Multiple breath washout testing to identify pulmonary chronic graft versus host disease in children after hematopoietic stem cell transplantation","volume":"28","author":"Rayment","year":"2022","journal-title":"Transplant Cell Ther"},{"issue":"8","key":"10.1016\/j.jtct.2025.01.885_bib0019","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1111\/ajt.15814","article-title":"Multicenter evaluation of parametric response mapping as an indicator of bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation","volume":"20","author":"Cheng","year":"2020","journal-title":"Am J Transplant"},{"issue":"5","key":"10.1016\/j.jtct.2025.01.885_bib0020","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01779-2018","article-title":"Xenon-129 MRI detects ventilation deficits in paediatric stem cell transplant patients unable to perform spirometry","volume":"53","author":"Walkup","year":"2019","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.jtct.2025.01.885_bib0021","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/bmt.2009.33","article-title":"Late-onset non-infectious pulmonary complications following allogeneic hematopoietic stem cell transplantation in children","volume":"44","author":"Nishio","year":"2009","journal-title":"Bone Marrow Transplant"},{"issue":"11","key":"10.1016\/j.jtct.2025.01.885_bib0022","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/bmt.2008.19","article-title":"Bronchiolitis obliterans following pediatric allogeneic hematopoietic stem cell transplantation","volume":"41","author":"Duncan","year":"2008","journal-title":"Bone Marrow Transplant"},{"issue":"9","key":"10.1016\/j.jtct.2025.01.885_bib0023","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1007\/s00247-019-04405-5","article-title":"Clinico-radiologic features of pleuroparenchymal fibroelastosis in children","volume":"49","author":"Nguyen","year":"2019","journal-title":"Pediatr Radiol"},{"issue":"3","key":"10.1016\/j.jtct.2025.01.885_bib0024","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.rcl.2019.12.006","article-title":"Imaging assessment of complications from transplantation from pediatric to adult patients: Part 2: Hematopoietic stem cell transplantation","volume":"58","author":"Concepcion","year":"2020","journal-title":"Radiol Clin North Am"},{"issue":"1","key":"10.1016\/j.jtct.2025.01.885_bib0025","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2214\/AJR.17.17866","article-title":"Imaging of abdominal and pelvic manifestations of graft-versus-host disease after hematopoietic stem cell transplant","volume":"209","author":"Lubner","year":"2017","journal-title":"AJR Am J Roentgenol"},{"issue":"suppl 4","key":"10.1016\/j.jtct.2025.01.885_bib0026","doi-asserted-by":"crossref","first-page":"e30013","DOI":"10.1002\/pbc.30013","article-title":"Imaging of pediatric hematopoietic stem cell transplant recipients: A COG Diagnostic Imaging Committee\/SPR Oncology Committee White Paper","volume":"70","author":"Chan","year":"2023","journal-title":"Pediatr Blood Cancer"},{"issue":"8","key":"10.1016\/j.jtct.2025.01.885_bib0027","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/sj.bmt.1703711","article-title":"Chronic graft-versus-host disease manifesting as polymyositis: an uncommon presentation","volume":"30","author":"Couriel","year":"2002","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"10.1016\/j.jtct.2025.01.885_bib0028","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s11926-021-00996-x","article-title":"Clinical characteristics of myositis associated with graft-versus-host disease","volume":"23","author":"Limaye","year":"2021","journal-title":"Curr Rheumatol Rep"},{"issue":"2","key":"10.1016\/j.jtct.2025.01.885_bib0029","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/bmt.2008.297","article-title":"Fasciitis and myositis: an analysis of muscle-related complications caused by chronic GVHD after allo-SCT","volume":"43","author":"Oda","year":"2009","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"10.1016\/j.jtct.2025.01.885_bib0030","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/bmt.2011.164","article-title":"Immunohistochemistry of affected tissue may guide cGVHD treatment decisions","volume":"47","author":"Williams","year":"2012","journal-title":"Bone Marrow Transplant"},{"issue":"9","key":"10.1016\/j.jtct.2025.01.885_bib0031","doi-asserted-by":"crossref","first-page":"759.e1","DOI":"10.1016\/j.jtct.2021.06.006","article-title":"Relevance of plasma matrix metalloproteinase-9 for bronchiolitis obliterans syndrome after allogeneic hematopoietic cell transplantation","volume":"27","author":"Inamoto","year":"2021","journal-title":"Transplant Cell Ther"},{"issue":"8","key":"10.1016\/j.jtct.2025.01.885_bib0032","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1111\/ajt.13750","article-title":"Proteomic characterization reveals that MMP-3 correlates with bronchiolitis obliterans syndrome following allogeneic hematopoietic cell and lung transplantation","volume":"16","author":"Liu","year":"2016","journal-title":"Am J Transplant"},{"issue":"7","key":"10.1016\/j.jtct.2025.01.885_bib0033","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/ppul.24801","article-title":"Long-term pulmonary function testing in pediatric bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation","volume":"55","author":"Walther","year":"2020","journal-title":"Pediatr Pulmonol"},{"issue":"11","key":"10.1016\/j.jtct.2025.01.885_bib0034","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1200\/JCO.22.00105","article-title":"Naive T-cell depletion to prevent GVHD: searching for a better mousetrap","volume":"40","author":"Soiffer","year":"2022","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.jtct.2025.01.885_bib0035","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1200\/JCO.21.01755","article-title":"Naive T-cell depletion to prevent chronic graft-versus-host disease","volume":"40","author":"Bleakley","year":"2022","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.jtct.2025.01.885_bib0036","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.bbmt.2019.11.015","article-title":"Anti-thymocyte globulin prophylaxis induces a decrease in naive Th cells to inhibit the onset of chronic graft-versus-host disease: results from the Canadian Bone Marrow Transplant Group (CBMTG) 0801 study","volume":"26","author":"Naeije","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"issue":"17","key":"10.1016\/j.jtct.2025.01.885_bib0037","doi-asserted-by":"crossref","first-page":"4886","DOI":"10.1182\/bloodadvances.2022007611","article-title":"Chronic GvHD NIH Consensus Project Biology Task Force: evolving path to personalized treatment of chronic GvHD","volume":"7","author":"Buxbaum","year":"2023","journal-title":"Blood Adv"},{"issue":"2","key":"10.1016\/j.jtct.2025.01.885_bib0038","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.bbmt.2016.09.023","article-title":"The biology of chronic graft-versus-host disease: A Task Force Report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease","volume":"23","author":"Cooke","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"issue":"12","key":"10.1016\/j.jtct.2025.01.885_bib0039","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1016\/j.bbmt.2011.05.011","article-title":"Early and late extensive chronic graft-versus-host disease in children is characterized by different Th1\/Th2 cytokine profiles: findings of the Children's Oncology Group Study ASCT0031","volume":"17","author":"Rozmus","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"issue":"5","key":"10.1016\/j.jtct.2025.01.885_bib0040","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1056\/NEJMoa2302892","article-title":"Health consequences of thymus removal in adults","volume":"389","author":"Kooshesh","year":"2023","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.jtct.2025.01.885_bib0041","doi-asserted-by":"crossref","first-page":"40","DOI":"10.4049\/jimmunol.1601100","article-title":"Immune reconstitution after allogeneic hematopoietic stem cell transplantation: time to T up the thymus","volume":"198","author":"Chaudhry","year":"2017","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.jtct.2025.01.885_bib0042","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.humimm.2019.03.003","article-title":"B cells in chronic graft-versus-host disease","volume":"80","author":"McManigle","year":"2019","journal-title":"Hum Immunol"},{"issue":"11","key":"10.1016\/j.jtct.2025.01.885_bib0043","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1182\/blood-2014-12-567834","article-title":"Aberrant B-cell homeostasis in chronic GVHD","volume":"125","author":"Sarantopoulos","year":"2015","journal-title":"Blood"},{"issue":"15","key":"10.1016\/j.jtct.2025.01.885_bib0044","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1182\/blood.2019003186","article-title":"Immune profile differences between chronic GVHD and late acute GVHD: results of the ABLE\/PBMTC 1202 studies","volume":"135","author":"Schultz","year":"2020","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.jtct.2025.01.885_bib0045","doi-asserted-by":"crossref","first-page":"772.e1","DOI":"10.1016\/j.jtct.2023.09.016","article-title":"Incidence and outcome of atypical manifestations of chronic graft-versus-host disease: results from a retrospective single-center analysis","volume":"29","author":"Doering","year":"2023","journal-title":"Transplant Cell Ther"},{"issue":"2","key":"10.1016\/j.jtct.2025.01.885_bib0046","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.bbmt.2018.09.031","article-title":"Characteristics of late fatal infections after allogeneic hematopoietic cell transplantation","volume":"25","author":"Norkin","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"10.1016\/j.jtct.2025.01.885_bib0047","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/bmt.2015.316","article-title":"The incidence, mortality and timing of Pneumocystis jirovecii pneumonia after hematopoietic cell transplantation: a CIBMTR analysis","volume":"51","author":"Williams","year":"2016","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"10.1016\/j.jtct.2025.01.885_bib0048","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.bbmt.2011.12.519","article-title":"Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation","volume":"18","author":"Majhail","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"issue":"12","key":"10.1016\/j.jtct.2025.01.885_bib0049","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1007\/s10096-010-1049-1","article-title":"Assessment of splenic function","volume":"29","author":"de Porto","year":"2010","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"5","key":"10.1016\/j.jtct.2025.01.885_bib0050","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1002\/pbc.25904","article-title":"Improved splenic function after hematopoietic stem cell transplant for sickle cell disease","volume":"63","author":"Nickel","year":"2016","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"10.1016\/j.jtct.2025.01.885_bib0051","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.4049\/jimmunol.1200391","article-title":"Graft-versus-host disease impairs vaccine responses through decreased CD4+ and CD8+ T cell proliferation and increased perforin-mediated CD8+ T cell apoptosis","volume":"190","author":"Capitini","year":"2013","journal-title":"J Immunol"},{"issue":"10","key":"10.1016\/j.jtct.2025.01.885_bib0052","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1086\/598324","article-title":"Randomized study of early versus late immunization with pneumococcal conjugate vaccine after allogeneic stem cell transplantation","volume":"48","author":"Cordonnier","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.jtct.2025.01.885_bib0053","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1093\/infdis\/jiv469","article-title":"Memory B-cell pools predict the immune response to pneumococcal conjugate vaccine in immunocompromised children","volume":"213","author":"Hoshina","year":"2016","journal-title":"J Infect Dis"},{"issue":"10","key":"10.1016\/j.jtct.2025.01.885_bib0054","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1016\/j.bbmt.2017.06.006","article-title":"Measuring immune response to commonly used vaccinations in adult recipients of allogeneic hematopoietic cell transplantation","volume":"23","author":"Kennedy","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"issue":"5","key":"10.1016\/j.jtct.2025.01.885_bib0055","doi-asserted-by":"crossref","first-page":"e13936","DOI":"10.1111\/petr.13936","article-title":"Patterns and correlates of preserved humoral immunity to vaccines in children following allogeneic hematopoietic stem cell transplantation","volume":"25","author":"Al-Antary","year":"2021","journal-title":"Pediatr Transplant"},{"issue":"3","key":"10.1016\/j.jtct.2025.01.885_bib0056","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.bbmt.2019.11.003","article-title":"Predictors of loss to follow-up among pediatric and adult hematopoietic cell transplantation survivors: a report from the Center for International Blood and Marrow Transplant Research","volume":"26","author":"Buchbinder","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"10.1016\/j.jtct.2025.01.885_bib0057","doi-asserted-by":"crossref","first-page":"109","DOI":"10.5581\/1516-8484.20120032","article-title":"Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation","volume":"34","author":"Majhail","year":"2012","journal-title":"Rev Bras Hematol Hemoter"},{"issue":"10","key":"10.1016\/j.jtct.2025.01.885_bib0058","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.bbmt.2009.06.019","article-title":"Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective","volume":"15","author":"Tomblyn","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"issue":"8","key":"10.1016\/j.jtct.2025.01.885_bib0059","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/bmt.2009.263","article-title":"Vaccination of hematopoietic cell transplant recipients","volume":"44","author":"Ljungman","year":"2009","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"10.1016\/j.jtct.2025.01.885_bib0060","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/s41409-021-01543-z","article-title":"Chronic graft-versus-host disease exacerbation after SARS-CoV-2 vaccination","volume":"57","author":"Trunk","year":"2022","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"10.1016\/j.jtct.2025.01.885_bib0061","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1038\/s41409-019-0438-z","article-title":"Prognosis of relapse after hematopoietic cell transplant (HCT) for treatment of leukemia or myelodysplastic syndrome (MDS) in children","volume":"54","author":"Dahlberg","year":"2019","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"10.1016\/j.jtct.2025.01.885_bib0062","doi-asserted-by":"crossref","first-page":"229","DOI":"10.7326\/M19-2936","article-title":"Survival, nonrelapse mortality, and relapse-related mortality after allogeneic hematopoietic cell transplantation: comparing 2003-2007 versus 2013-2017 cohorts","volume":"172","author":"McDonald","year":"2020","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.jtct.2025.01.885_bib0063","doi-asserted-by":"crossref","first-page":"362.e1","DOI":"10.1016\/j.jtct.2023.02.020","article-title":"Late relapse after hematopoietic stem cell transplantation for acute leukemia: a retrospective study by SFGM-TC","volume":"29","author":"Kaphan","year":"2023","journal-title":"Transplant Cell Ther"},{"issue":"3","key":"10.1016\/j.jtct.2025.01.885_bib0064","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1182\/blood.V75.3.555.555","article-title":"Graft-versus-leukemia reactions after bone marrow transplantation","volume":"75","author":"Horowitz","year":"1990","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.jtct.2025.01.885_bib0065","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/ajh.25750","article-title":"Harnessing the immune system after allogeneic stem cell transplant in acute myeloid leukemia","volume":"95","author":"Sterling","year":"2020","journal-title":"Am J Hematol"},{"issue":"2","key":"10.1016\/j.jtct.2025.01.885_bib0066","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1182\/blood-2011-01-330217","article-title":"Influence of immunosuppressive treatment on risk of recurrent malignancy after allogeneic hematopoietic cell transplantation","volume":"118","author":"Inamoto","year":"2011","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.jtct.2025.01.885_bib0067","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1200\/JCO.22.01203","article-title":"Secondary neoplasms after hematopoietic cell transplant for sickle cell disease","volume":"41","author":"Eapen","year":"2023","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1016\/j.jtct.2025.01.885_bib0068","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/j.bbmt.2014.08.004","article-title":"Nonmyeloablative allogeneic hematopoietic stem cell transplantation for GATA2 deficiency","volume":"20","author":"Grossman","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"issue":"30","key":"10.1016\/j.jtct.2025.01.885_bib0069","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.1200\/JCO.2012.42.3038","article-title":"Delivering care to long-term adult survivors of hematopoietic cell transplantation","volume":"30","author":"Syrjala","year":"2012","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.jtct.2025.01.885_bib0070","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1001\/jamaoncol.2018.4934","article-title":"Evaluation of second solid cancers after hematopoietic stem cell transplantation in European patients","volume":"5","author":"Tichelli","year":"2019","journal-title":"JAMA Oncol"},{"issue":"23","key":"10.1016\/j.jtct.2025.01.885_bib0071","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.2217\/fon.15.252","article-title":"Risk of secondary solid malignancies after allogeneic hematopoietic stem cell transplantation and preventive strategies","volume":"11","author":"Adhikari","year":"2015","journal-title":"Future Oncol"},{"issue":"5","key":"10.1016\/j.jtct.2025.01.885_bib0072","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1182\/blood-2008-05-158782","article-title":"Solid cancers after allogeneic hematopoietic cell transplantation","volume":"113","author":"Rizzo","year":"2009","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.jtct.2025.01.885_bib0073","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1038\/s41409-022-01786-4","article-title":"Survival and late effects of hematopoietic cell transplantation in patients with thalassemia major","volume":"57","author":"Santarone","year":"2022","journal-title":"Bone Marrow Transplant"},{"issue":"16","key":"10.1016\/j.jtct.2025.01.885_bib0074","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1002\/cncr.33587","article-title":"The ever-increasing importance of cancer as a leading cause of premature death worldwide","volume":"127","author":"Bray","year":"2021","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.jtct.2025.01.885_bib0075","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1002\/ijc.25517","article-title":"Fifty years of cancer incidence: CI5 I-IX","volume":"127","author":"Parkin","year":"2010","journal-title":"Int J Cancer"},{"issue":"3","key":"10.1016\/j.jtct.2025.01.885_bib0076","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/bjc.2011.250","article-title":"What is the lifetime risk of developing cancer?: the effect of adjusting for multiple primaries","volume":"105","author":"Sasieni","year":"2011","journal-title":"Br J Cancer"},{"issue":"10","key":"10.1016\/j.jtct.2025.01.885_bib0077","doi-asserted-by":"crossref","first-page":"3802","DOI":"10.1182\/blood-2004-09-3411","article-title":"Impact of chronic GVHD therapy on the development of squamous-cell cancers after hematopoietic stem-cell transplantation: an international case-control study","volume":"105","author":"Curtis","year":"2005","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.jtct.2025.01.885_bib0078","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1182\/bloodadvances.2019000839","article-title":"Subsequent neoplasms and late mortality in children undergoing allogeneic transplantation for nonmalignant diseases","volume":"4","author":"Kahn","year":"2020","journal-title":"Blood Adv"},{"issue":"2","key":"10.1016\/j.jtct.2025.01.885_bib0079","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/leu.2014.203","article-title":"Second cancers and late mortality in Australian children treated by allogeneic HSCT for haematological malignancy","volume":"29","author":"Nelson","year":"2015","journal-title":"Leukemia"},{"issue":"9","key":"10.1016\/j.jtct.2025.01.885_bib0080","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/j.bbmt.2017.05.022","volume":"23","author":"Dietz","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"issue":"20","key":"10.1016\/j.jtct.2025.01.885_bib0081","doi-asserted-by":"crossref","first-page":"4992","DOI":"10.1182\/blood-2008-09-178046","article-title":"Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation","volume":"113","author":"Landgren","year":"2009","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.jtct.2025.01.885_bib0082","first-page":"2208","article-title":"Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study","volume":"94","author":"Curtis","year":"1999","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.jtct.2025.01.885_bib0083","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/j.bbmt.2019.02.016","article-title":"Risk factors and predictive scoring system for post-transplant lymphoproliferative disorder after hematopoietic stem cell transplantation","volume":"25","author":"Fujimoto","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"issue":"8","key":"10.1016\/j.jtct.2025.01.885_bib0084","doi-asserted-by":"crossref","first-page":"e70349","DOI":"10.1371\/journal.pone.0070349","article-title":"Human papillomavirus-associated subsequent malignancies among long-term survivors of pediatric and young adult cancers","volume":"8","author":"Ojha","year":"2013","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.jtct.2025.01.885_bib0085","doi-asserted-by":"crossref","first-page":"435.e1","DOI":"10.1016\/j.jtct.2020.12.028","article-title":"Hematopoietic cell transplantation and outcomes related to human papillomavirus disease in GATA2 deficiency","volume":"27","author":"Parta","year":"2021","journal-title":"Transplant Cell Ther"},{"issue":"9","key":"10.1016\/j.jtct.2025.01.885_bib0086","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.bbmt.2008.07.005","article-title":"Increased risk of cervical dysplasia in long-term survivors of allogeneic stem cell transplantation\u2014implications for screening and HPV vaccination","volume":"14","author":"Savani","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"issue":"8","key":"10.1016\/j.jtct.2025.01.885_bib0087","doi-asserted-by":"crossref","first-page":"662.e1","DOI":"10.1016\/j.jtct.2021.04.014","article-title":"Engrafted donor-derived clonal hematopoiesis after allogenic hematopoietic cell transplantation is associated with chronic graft-versus-host disease requiring immunosuppressive therapy, but no adverse impact on overall survival or relapse","volume":"27","author":"Newell","year":"2021","journal-title":"Transplant Cell Ther"},{"issue":"3","key":"10.1016\/j.jtct.2025.01.885_bib0088","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jtct.2023.10.018","article-title":"Donor-derived malignancy and transplantation morbidity: risks of patient and donor genetics in allogeneic hematopoietic stem cell transplantation","volume":"30","author":"Williams","year":"2024","journal-title":"Transplant Cell Ther"},{"issue":"6","key":"10.1016\/j.jtct.2025.01.885_bib0089","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1001\/jama.2017.9938","article-title":"Effect of azithromycin on airflow decline-free survival after allogeneic hematopoietic stem cell transplant: the ALLOZITHRO randomized clinical trial","volume":"318","author":"Bergeron","year":"2017","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.jtct.2025.01.885_bib0090","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.bbmt.2019.10.025","article-title":"Azithromycin use and increased cancer risk among patients with bronchiolitis obliterans after hematopoietic cell transplantation","volume":"26","author":"Cheng","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"10.1016\/j.jtct.2025.01.885_bib0091","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1038\/s41409-020-01095-8","article-title":"Risk of relapse in patients receiving azithromycin after allogeneic HSCT","volume":"56","author":"Kutzke","year":"2021","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1016\/j.jtct.2025.01.885_bib0092","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.rdc.2015.08.004","article-title":"Infection risk and safety of corticosteroid use","volume":"42","author":"Youssef","year":"2016","journal-title":"Rheum Dis Clin North Am"},{"issue":"4","key":"10.1016\/j.jtct.2025.01.885_bib0093","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1080\/08880018.2020.1868637","article-title":"Ruxolitinib for steroid-refractory graft-versus-host disease in pediatric HSCT: high response rate and manageable toxicity","volume":"38","author":"Mozo","year":"2021","journal-title":"Pediatr Hematol Oncol"},{"issue":"3","key":"10.1016\/j.jtct.2025.01.885_bib0094","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/ajh.25376","article-title":"Ruxolitinib treatment for steroid refractory acute and chronic graft-vs-host disease in children: clinical and immunological results","volume":"94","author":"Gonzalez Vicent","year":"2019","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jtct.2025.01.885_bib0095","article-title":"Efficiency and toxicity of ruxolitinib as a salvage treatment for steroid-refractory chronic graft-versus-host disease","volume":"12","author":"Wang","year":"2021","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.jtct.2025.01.885_bib0096","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s40272-023-00577-8","article-title":"Ruxolitinib treatment of steroid-refractory graft-versus-host disease in children: a case series and review of the literature","volume":"25","author":"Yan","year":"2023","journal-title":"Paediatr Drugs"},{"issue":"6","key":"10.1016\/j.jtct.2025.01.885_bib0097","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/s41409-022-01673-y","article-title":"Safety analysis of patients who received ruxolitinib for steroid-refractory acute or chronic graft-versus-host disease in an expanded access program","volume":"57","author":"Schroeder","year":"2022","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"10.1016\/j.jtct.2025.01.885_bib0098","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1080\/1744666X.2023.2152330","article-title":"A critical review of belumosudil in adult and pediatric patients with chronic graft-versus-host disease","volume":"19","author":"Salhotra","year":"2023","journal-title":"Expert Rev Clin Immunol"},{"issue":"10","key":"10.1016\/j.jtct.2025.01.885_bib0099","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1200\/JCO.22.00958","article-title":"Axatilimab for chronic graft-versus-host disease after failure of at least two prior systemic therapies: results of a phase I\/II study","volume":"41","author":"Kitko","year":"2023","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.jtct.2025.01.885_bib0100","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.bbmt.2014.11.674","article-title":"Impact of serotherapy on immune reconstitution and survival outcomes after stem cell transplantations in children: thymoglobulin versus alemtuzumab","volume":"21","author":"Willemsen","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"10.1016\/j.jtct.2025.01.885_bib0101","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.bbmt.2018.10.008","article-title":"Immune reconstitution and infection patterns after early alemtuzumab and reduced intensity transplantation for nonmalignant disorders in pediatric patients","volume":"25","author":"Bhatt","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"issue":"11","key":"10.1016\/j.jtct.2025.01.885_bib0102","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/j.bbmt.2013.09.003","article-title":"In vivo T cell costimulation blockade with abatacept for acute graft-versus-host disease prevention: a first-in-disease trial","volume":"19","author":"Koura","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"issue":"10","key":"10.1016\/j.jtct.2025.01.885_bib0103","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1182\/bloodadvances.2022008545","article-title":"Abatacept GVHD prophylaxis in unrelated hematopoietic cell transplantation for pediatric bone marrow failure","volume":"7","author":"Stenger","year":"2023","journal-title":"Blood Adv"},{"issue":"1","key":"10.1016\/j.jtct.2025.01.885_bib0104","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3324\/haematol.2022.281134","article-title":"Rituximab therapy after pediatric hematopoietic stem cell transplantation can cause prolonged B-cell impairment and increases the risk for infections - a retrospective matched cohort study","volume":"108","author":"Launspach","year":"2023","journal-title":"Haematologica"},{"issue":"21","key":"10.1016\/j.jtct.2025.01.885_bib0105","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1182\/blood-2017-07-793786","article-title":"Ibrutinib for chronic graft-versus-host disease after failure of prior therapy","volume":"130","author":"Miklos","year":"2017","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.jtct.2025.01.885_bib0106","doi-asserted-by":"crossref","first-page":"e13692","DOI":"10.1111\/petr.13692","article-title":"Ibrutinib for the treatment of chronic graft-vs-host disease in pediatric hematopoietic stem cell transplant patients: a single-center experience","volume":"24","author":"Teusink-Cross","year":"2020","journal-title":"Pediatr Transplant"},{"issue":"3","key":"10.1016\/j.jtct.2025.01.885_bib0107","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.bbmt.2012.01.003","volume":"18","author":"Pulsipher","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"issue":"10","key":"10.1016\/j.jtct.2025.01.885_bib0108","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.17219\/acem\/126739","article-title":"Secondary skin neoplasms in patients after autologous and allogeneic hematopoietic stem cell transplantation procedures","volume":"29","author":"Szlauer-Stefanska","year":"2020","journal-title":"Adv Clin Exp Med"},{"issue":"11","key":"10.1016\/j.jtct.2025.01.885_bib0109","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.1182\/blood-2010-10-263095","article-title":"How I treat late effects in adults after allogeneic stem cell transplantation","volume":"117","author":"Savani","year":"2011","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.jtct.2025.01.885_bib0110","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1182\/hematology.2020000095","article-title":"Special pre- and posttransplant considerations in inherited bone marrow failure and hematopoietic malignancy predisposition syndromes","volume":"2020","author":"Bonfim","year":"2020","journal-title":"Hematology Am Soc Hematol Educ Program"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636725009133?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636725009133?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T02:11:19Z","timestamp":1780279879000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636725009133"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":110,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S2666636725009133"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2025.01.885","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pediatric Transplant and Cellular Therapy Consortium RESILIENT Conference on Pediatric Chronic Graft-versus-Host Disease Survivorship after Hematopoietic Cell Transplantation: Part II. Organ Dysfunction and Immune Reconstitution Considerations for Children with Chronic Graft-versus-Host Disease after Hematopoietic Cell Transplantation","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2025.01.885","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}